- Home
- CADL vs FCEL Comparison
CADL vs FCEL Comparison
Compare CADL & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- FCEL
- Stock Information
- Founded
- CADL 1999
- FCEL 1969
- Country
- CADL United States
- FCEL United States
- Employees
- CADL N/A
- FCEL N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- FCEL Industrial Machinery/Components
- Sector
- CADL Health Care
- FCEL Energy
- Exchange
- CADL Nasdaq
- FCEL Nasdaq
- Market Cap
- CADL 339.8M
- FCEL 273.9M
- IPO Year
- CADL 2021
- FCEL 1992
- Fundamental
- Price
- CADL $5.60
- FCEL $7.63
- Analyst Decision
- CADL Strong Buy
- FCEL Hold
- Analyst Count
- CADL 7
- FCEL 5
- Target Price
- CADL $19.57
- FCEL $8.13
- AVG Volume (30 Days)
- CADL 852.2K
- FCEL 4.5M
- Earning Date
- CADL 11-13-2025
- FCEL 12-18-2025
- Dividend Yield
- CADL N/A
- FCEL N/A
- EPS Growth
- CADL N/A
- FCEL N/A
- EPS
- CADL N/A
- FCEL N/A
- Revenue
- CADL N/A
- FCEL $152,472,000.00
- Revenue This Year
- CADL N/A
- FCEL $34.68
- Revenue Next Year
- CADL N/A
- FCEL $25.52
- P/E Ratio
- CADL N/A
- FCEL N/A
- Revenue Growth
- CADL N/A
- FCEL 78.81
- 52 Week Low
- CADL $3.79
- FCEL $3.58
- 52 Week High
- CADL $14.60
- FCEL $13.98
- Technical
- Relative Strength Index (RSI)
- CADL 50.83
- FCEL 43.73
- Support Level
- CADL $5.11
- FCEL $7.47
- Resistance Level
- CADL $5.52
- FCEL $8.29
- Average True Range (ATR)
- CADL 0.39
- FCEL 0.90
- MACD
- CADL -0.04
- FCEL -0.38
- Stochastic Oscillator
- CADL 32.89
- FCEL 3.54
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.